Understanding cancer biology and the development of novel agents for cancer treatment
has always been the goal of cancer researchers. However, the research and development of …

Background Repurposing antifungal drugs in cancer therapy has attracted unprecedented
attention in both preclinical and clinical research due to specific advantages, such as safety …

Cancer is amenable to low-cost treatments, given that it has a significant metabolic
component, which can be affected through diet and lifestyle change at minimal cost. The …

Methods Related articles published in the PubMed database between 05/30/2008 to
09/10/2022 were identified using the following terms:“lncRNA AND miRNA AND esophageal …

Background/Aim: Combination chemotherapy with gemcitabine, nab-paclitaxel, oxaliplatin,
and itraconazole (GnPO-ITC) was administered as first-line chemotherapy in patients with …

Background: Cutaneous squamous cell carcinoma (cSCC) is a common cutaneous cancer
with increasing incidence. Itraconazole has been identified as a potential anticancer drug …

Simple Summary We present eight core attributes of cancer growth that we must address for
a more effective treatment than we currently have. To do this we outline why a regimen …

COPD affects millions of people and is now ranked as the third leading cause of death
worldwide. This largely untreatable chronic airway disease results in irreversible destruction …

Esophageal cancer (EC), as one of the leading causes of cancer‐associated mortality,
influences a remarkable population of subjects globally and is histologically divided into two …

There is an urgent necessity to devise efficient tactics to tackle the inevitable development of
resistance to osimertinib, which is a third‐generation epidermal growth factor receptor …